Virtu KCG Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$560K Sell
17,567
-57,880
-77% -$1.83M 0.02% 1044
2017
Q1
$2.45M Sell
75,447
-31,464
-29% -$992K 0.07% 195
2016
Q4
$3.29M Buy
106,911
+47,462
+80% +$1.45M 0.08% 136
2016
Q3
$1.91M Buy
59,449
+6,718
+13% +$225K 0.05% 329
2016
Q2
$1.76M Sell
52,731
-93,966
-64% -$3M 0.04% 406
2016
Q1
$4.13M Buy
146,697
+126,471
+625% +$3.61M 0.12% 90
2015
Q4
$619K Buy
20,226
+11,545
+133% +$363K 0.01% 1310
2015
Q3
$259K Sell
8,681
-140,500
-94% -$4.5M ﹤0.01% 2260
2015
Q2
$4.75M Buy
149,181
+38,503
+35% +$1.25M 0.08% 141
2015
Q1
$3.65M Buy
110,678
+81,290
+277% +$2.58M 0.07% 176
2014
Q4
$869K Sell
29,388
-113,320
-79% -$3.25M 0.01% 1083
2014
Q3
$4M Buy
142,708
+22,206
+18% +$623K 0.08% 191
2014
Q2
$3.39M Sell
120,502
-54,319
-31% -$1.55M 0.05% 288
2014
Q1
$5.33M Sell
174,821
-15,940
-8% -$475K 0.07% 243
2013
Q4
$5.54M Buy
190,761
+14,582
+8% +$424K 0.06% 210
2013
Q3
$4.8M Buy
+176,179
New +$4.79M 0.06% 234

Other funds holding PFE

Virtu KCG Holdings's PFE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Pfizer (PFE) stake by 77% in Q2 2017, selling an estimated $1.83M and leaving 17,567 shares worth $560K. The position accounts for 0.02% of the portfolio, ranked #1044.

Virtu KCG Holdings first reported a position in PFE in Q3 2013 and has held it in 16 quarters since. The position peaked at $5.54M in Q4 2013. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Virtu KCG Holdings held 17,567 shares of Pfizer worth $560K as of Q2 2017.
  • Virtu KCG Holdings sold 57,880 Pfizer shares in Q2 2017, an estimated $1.83M.
  • Pfizer made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #1044 holding.
  • Virtu KCG Holdings first reported a position in Pfizer in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Pfizer position peaked at $5.54M in Q4 2013.
  • 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.